Thiogenesis Therapeutics Corp (TTI.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 02-2022 | 12-2021 | |
| Operating Expenses | 3,579 | 5,206 | 1,975 | 225 | 1,279 |
| Operating Income | -3,579 | -5,206 | -1,975 | -225 | -1,279 |
| Interest Expense | N/A | 0 | 4 | 0 | 3 |
| Other Income | 434 | 143 | -1,945 | 0 | 64 |
| Pre-tax Income | -3,146 | -5,063 | -3,924 | -224 | -1,218 |
| Net Income Continuous | -3,146 | -5,063 | -3,924 | -224 | -1,218 |
| Net Income | $-3,146 | $-5,063 | $-3,924 | $-224 | $-1,218 |
| EPS Basic Total Ops | -0.07 | -0.13 | -0.16 | -0.01 | -0.04 |
| EPS Basic Continuous Ops | -0.07 | -0.13 | -0.16 | N/A | N/A |
| EPS Diluted Total Ops | -0.07 | -0.13 | -0.16 | -0.01 | -0.04 |
| EPS Diluted Continuous Ops | -0.07 | -0.13 | -0.16 | N/A | N/A |
| EBITDA(a) | $-3,579 | $-5,063 | $-3,920 | $-224 | $-1,215 |